Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease
Data Supplement
Files in this Data Supplement:
This Article
-
doi: 10.2337/diacare.27.8.1897 Diabetes Care August 2004 vol. 27 no. 8 1897-1903
- AbstractFree
- Full Text
- Full Text (PDF)
- » Appendix
Current Issue
From the Cover
- Driving mishaps among individuals with type 1 diabetes: a prospective study
- Projecting the future diabetes population size and related costs for the U.S.
- Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus
- Are metabolically normal but obese individuals at lower risk for all-cause mortality?
